Drugs affecting the gastrointestinal system

ERG1 encodes the pore forming alpha subunit of the voltage-gated channels that conduct the rapid delayed rectifier potassium current, which leads to termination of the cardiac ventricular action potential. A large number of commercially available

Specificity Recognizes a full length Kir3.2 (GIRK2, G-protein Activated Inwardly Rectifying Potassium Channel 2).

The gene K2P4.1, also referred to as KCNK4 (potassium two pore domain channel subfamily K member 4), encodes a protein belonging to the subfamily of K2P (two pore domain K + channel) channels called TRAAK (TWIK-related arachidonic acid-stimulated K

KCNQ5 is subunit one of a voltage gated potassium channel expressed in the brain and other tissues. KCNQ5 forms the complete channel with KCNQ3.

Specificity Recognizes Kir2.1 protein (IRK1, Kcnj2).

Anti-Potassium Channel Kv1.3 Antibody detects level of Potassium Channel Kv1.

Anti-Potassium Channel Kv1.3 Antibody detects level of Potassium Channel Kv1.

Immunogen peptideTTRKAQEIHGKAPG (C) corresponding to residues 2-15 of mouse Kv1.7.

Specificity Recognizes a full length Kv3.1b protein.

Immunogen prolactin Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The

Immunogen prolactin Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The

Immunogen RAB GTPase activating protein 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in